Exercise Conditions

Exercise Conditions. On or after the Exercisability Date, the Closing Sale Price per share of the Common Stock is greater than or equal to one dollar ($1.00) (as adjusted for splits, recapitalization and the like) for a period of ten (10) out of twenty (20) consecutive Trading Days following the date that is six months after the closing date of the offering pursuant to which the Company was obligated to issue this Warrant, provided, however, that: i) during the twenty (20) Trading Day period referred to in... this Section 17(f), the Common Stock must trade at an average dollar-volume of at least $50,000 per Trading Day; and ii) either: 1. a Registration Statement (as defined in that certain Registration Rights Agreement, dated as of the hereof, between the Company, the Holder and the other signatories thereto (the "RRA")) or Registration Statements covering all of the Registrable Securities (as defined in the RRA) shall have been filed with and declared effective under the Securities Act by the U.S. Securities and Exchange Commission and shall have remained continuously effective under the Securities Act during the entire twenty (20) consecutive Trading Day period referred to in this Section 17(f); or 2. the Holder shall have been permitted to sell all of the Registrable Securities held by such Holder pursuant to Rule 144 under the Securities Act during the entire twenty (20) consecutive Trading Day period referred to in this Section 17(f). View More

Exercise Conditions. Means the public announcement of Top-Line Data from the CATT1 Trial that includes the primary endpoint of reduction in the incidence of Level 2 hypoglycemia and Level 3 hypoglycemia in cadisegliatin-treated subjects compared to placebo having been met, defined as a statistically significant difference favoring cadisegliatin, with a 95% confidence level.

Exercise Conditions. Means all of the following conditions: (i) for any 10-day period, the average Closing Sale Price per share of Common Stock is greater than or equal to 200% of the Exercise Price then in effect (as adjusted for additional issuances, splits, recapitalization and the like), (ii) the total daily trading volume for the shares of Common Stock over the same 10 day period referenced in (i) above equals or exceeds 750,000 shares, and (iii) all of the Warrant Shares have been registered for resale... pursuant to the Securities Act of 1933, as amended and such registration statement is effective, or may be sold pursuant to an exemption from the registration requirements of Securities Act of 1933, as amended. View More

Exercise Conditions. Has the meaning set forth in Section ‎2(iii).

Exercise Conditions. Means any Trading Day following the Company's public announcement of (i) an overall response rate (defined as Complete Response, or CR, and Complete Response with partial hematologic recovery, or CRh) equaling or exceeding 30% in the first 15 (or more) patients enrolled in Part 2 of the volasertib Phase 2 clinical trial, and (ii) a median response duration of at least 90 days (among patients with a minimal follow-up of 90 days after clinical response) or incidence of grade 4/5 infections less... than or equal to 30% for the first 10 (or more) patients enrolled in Part 2 of the volasertib Phase 2 clinical trial, on which the Ordinary Share is trading on a Trading Market, OTCQB or OTCQX, as applicable, at a price equaling or exceeding 200% of the then applicable Exercise Price. View More

Exercise Conditions. All of the following conditions (i) the Closing Sale Price per share of the Common Stock is greater than or equal to thirty dollars ($30.00) (as adjusted for splits, recapitalization and the like) for a consecutive period of thirty-one (31) trading days and (ii) the average daily trading volume for the shares of Common Stock over the same 31-day period referenced in (i) above equals or exceeds 65,000 shares

Exercise Conditions. The Company's achievement of consolidated trailing twelve-month Adjusted EBITDA of $12 million for any twelve month period during the term of the Warrant.

Exercise Conditions. Means the occurrence of the closing price of the Company's Common Stock on an Eligible Market equaling or exceeding 200% of the Exercise Price for at least 40 consecutive Trading Days.

Exercise Conditions. Means the public announcement of top-line data from the Company's randomized withdrawal period of Study C602 stating that the primary endpoint of change from baseline in hyperphagia, defined as statistically significant with a p<0.05, was met and no new significant safety signals were identified. Such public announcement must contain a statement that the Company intends to submit a New Drug Application for DCCR based on the data obtained from the randomized withdrawal period of Study C602.

Exercise Conditions. Means that the Company's receipt of the Food and Drug Administration's marketing approval for DCCR (Diazoxide Choline) Extended-Release tablets for the treatment of Prader-Willi syndrome (PWS).